Back to User profile » Professor David Price

Papers published by Professor David Price:


Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma

Price D, Menzies-Gow A, Bachert C, Canonica GW, Kocks J, Khan AH, Ye F, Rowe PJ, Lu Y, Kamat S, Carter V, Voorham J

Journal of Asthma and Allergy 2021, 14:1173-1183

Published Date: 29 September 2021

CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care

Pullen R, Miravitlles M, Sharma A, Singh D, Martinez F, Hurst JR, Alves L, Dransfield M, Chen R, Muro S, Winders T, Blango C, Muellerova H, Trudo F, Dorinsky P, Alacqua M, Morris T, Carter V, Couper A, Jones R, Kostikas K, Murray R, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2301-2322

Published Date: 12 August 2021

Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients

Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M, Price D

Pragmatic and Observational Research 2021, 12:93-104

Published Date: 11 August 2021

High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma

Baron AJ, Flokstra-de Blok BM, Kerstjens HAM, Koopmans-Klein G, Price DB, Sellink AA, Tsiligianni I, Kocks JWH

Journal of Asthma and Allergy 2021, 14:851-861

Published Date: 12 July 2021

Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study

Tran TN, Kerkhof M, Carter V, Price DB

Journal of Asthma and Allergy 2021, 14:727-742

Published Date: 25 June 2021

Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes

Price D, Jones R, Pfister P, Cao H, Carter V, Kemppinen A, Holzhauer B, Kaplan A, Clark A, Halpin DMG, Pinnock H, Chalmers JD, van Boven JF, Beeh KM, Kostikas K, Roche N, Usmani OA, Mastoridis P

Pragmatic and Observational Research 2021, 12:25-35

Published Date: 24 May 2021

MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis

van Weissenbruch R, Klimek L, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, Kuhl HC, Pohl W, Scadding GK, Price D, Mullol J

Journal of Asthma and Allergy 2020, 13:633-645

Published Date: 2 December 2020

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3093-3103

Published Date: 26 November 2020

Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study

Voorham J, Baldi S, Santoro L, Kerkhof M, Contoli M, Fabbri LM, Kerstjens HAM, Luis López-Campos J, Roche N, Singh D, Vogelmeier CF, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2739-2750

Published Date: 29 October 2020

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database [Corrigendum]

Kostikas K, Price D, Gutzwiller FS, Jones B, Loefroth E, Clemens A, Fogel R, Jones R, Cao H

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2559-2560

Published Date: 16 October 2020

The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients

Kritikos V, Price D, Papi A, Infantino A, Ställberg B, Ryan D, Lavorini F, Chrystyn H, Haughney J, Lisspers K, Gruffydd-Jones K, Román Rodríguez M, Høegh Henrichsen S, van der Molen T, Carter V, Bosnic-Anticevich S

Journal of Asthma and Allergy 2020, 13:415-428

Published Date: 6 October 2020

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline

Kerkhof M, Voorham J, Dorinsky P, Cabrera C, Darken P, Kocks JWH, Sadatsafavi M, Sin DD, Carter V, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1909-1918

Published Date: 6 August 2020

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database

Kostikas K, Price D, Gutzwiller FS, Jones B, Loefroth E, Clemens A, Fogel R, Jones R, Cao H

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1729-1738

Published Date: 16 July 2020

Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study

Kostikas K, Rhee CK, Hurst JR, Agostoni P, Cao H, Fogel R, Jones R, Kocks JWH, Mezzi K, Wan Yau Ming S, Ryan R, Price DB

Pragmatic and Observational Research 2020, 11:55-66

Published Date: 2 June 2020

Treatment Adherence in Adolescents with Asthma

Kaplan A, Price D

Journal of Asthma and Allergy 2020, 13:39-49

Published Date: 14 January 2020

Management Of Community-Acquired Pneumonia: An Observational Study In UK Primary Care

Launders N, Ryan D, Winchester CC, Skinner D, Konduru PR, Price DB

Pragmatic and Observational Research 2019, 10:53-65

Published Date: 23 September 2019

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes [Corrigendum]

Bosnic-Anticevich S, Chrystyn H, Costello R, Dolovich MB, Fletcher M, Lavorini F, Rodríguez-Roisin R, Ryan D, Wan Yau Ming S, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1739-1740

Published Date: 2 August 2019

Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study

Kim KY, Miravitlles M, Sliwinski P, Costello R, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price D, Rhee CK

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1595-1601

Published Date: 25 July 2019

Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation

Price DB, Yang S, Wan Yau Ming S, Hardjojo A, Cabrera C, Papaioannou AI, Loukides S, Kritikos V, Bosnic-Anticevich SZ, Carter V, Dorinsky PM

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3937-3946

Published Date: 13 December 2018

Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks

Grigg J, Nibber A, Paton JY, Chisholm A, Guilbert TW, Kaplan A, Turner S, Roche N, Hillyer EV, Price DB

Journal of Asthma and Allergy 2018, 11:309-321

Published Date: 11 December 2018

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study

Price DB, Trudo F, Voorham J, Xu X, Kerkhof M, Ling Zhi Jie J, Tran TN

Journal of Asthma and Allergy 2018, 11:193-204

Published Date: 29 August 2018

Real-life treatment of rhinitis in Australia: a historical cohort study of prescription and over-the-counter therapies for patients with and without additional respiratory disease

Price DB, Smith PK, Harvey RJ, Carney AS, Kritikos V, Bosnic-Anticevich SZ, Christian L, Skinner D, Carter V, Durieux AMS

Pragmatic and Observational Research 2018, 9:43-54

Published Date: 15 August 2018

Predicting frequent COPD exacerbations using primary care data [Corrigendum]

Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2471-2472

Published Date: 15 August 2018

Performance of database-derived severe exacerbations and asthma control measures in asthma: responsiveness and predictive utility in a UK primary care database with linked questionnaire data

Colice G, Chisholm A, Dima AL, Reddel HK, Burden A, Martin RJ, Brusselle G, Popov TA, von Ziegenweidt J, Price DB

Pragmatic and Observational Research 2018, 9:29-42

Published Date: 10 August 2018

Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey [Erratum]

Price D, Keininger DL, Viswanad B, Gasser M, Walda S, Gutzwiller FS

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2253-2254

Published Date: 25 July 2018

Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey

Price D, Keininger DL, Viswanad B, Gasser M, Walda S, Gutzwiller FS

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:695-702

Published Date: 26 February 2018

The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship

Colice G, Price D, Gerhardsson de Verdier M, Rabon-Stith K, Ambrose C, Cappell K, Irwin DE, Juneau P, Vlahiotis A

Pragmatic and Observational Research 2017, 8:231-240

Published Date: 1 December 2017

Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study

Carney AS, Price DB, Smith PK, Harvey R, Kritikos V, Bosnic-Anticevich SZ, Christian L, Skinner DA, Carter V, Durieux AMS

Pragmatic and Observational Research 2017, 8:157-165

Published Date: 30 August 2017

Asthma referrals: a key component of asthma management that needs to be addressed

Price D, Bjermer L, Bergin DA, Martinez R

Journal of Asthma and Allergy 2017, 10:209-223

Published Date: 25 July 2017

Effective deployment of technology-supported management of chronic respiratory conditions: a call for stakeholder engagement

Costello RW, Dima AL, Ryan D, McIvor RA, Boycott K, Chisholm A, Price D, Blakey JD

Pragmatic and Observational Research 2017, 8:119-128

Published Date: 5 July 2017

Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases

Smith P, Price D, Harvey R, Carney AS, Kritikos V, Bosnic-Anticevich SZ, Christian L, Skinner D, Carter V, Durieux AMS

Journal of Asthma and Allergy 2017, 10:153-161

Published Date: 9 May 2017

Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study

Dollerup J, Vestbo J, Murray-Thomas T, Kaplan A, Martin RJ, Pizzichini E, Pizzichini MMM, Burden A, Martin J, Price DB

Clinical Epidemiology 2017, 9:231-243

Published Date: 26 April 2017

Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study

Voorham J, Vrijens B, van Boven JFM, Ryan D, Miravitlles M, Law LM, Price DB

Pragmatic and Observational Research 2017, 8:31-41

Published Date: 18 April 2017

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma

Burden A, Roche N, Miglio C, Hillyer EV, Postma DS, Herings RMC, Overbeek JA, Khalid JM, van Eickels D, Price DB

Pragmatic and Observational Research 2017, 8:15-30

Published Date: 22 March 2017

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:907-922

Published Date: 17 March 2017

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

Bosnic-Anticevich S, Chrystyn H, Costello RW, Dolovich MB, Fletcher MJ, Lavorini F, Rodríguez-Roisin R, Ryan D, Wan Yau Ming S, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:59-71

Published Date: 21 December 2016

Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database

Lee H, Rhee CK, Lee BJ, Choi DC, Kim JA, Kim SH, Jeong Y, Kim TH, Chon GR, Jung KS, Lee SH, Price D, Yoo KH, Park HY

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:775-783

Published Date: 15 April 2016

Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C

Journal of Asthma and Allergy 2016, 9:1-12

Published Date: 7 January 2016

Predicting frequent COPD exacerbations using primary care data

Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2439-2450

Published Date: 9 November 2015

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK

Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2207-2217

Published Date: 15 October 2015

Time for a new language for asthma control: results from REALISE Asia

Price D, David-Wang A, Cho SH, Ho JCM, Jeong JW, Liam CK, Lin JT, Muttalif AR, Perng DW, Tan TL, Yunus F, Neira G

Journal of Asthma and Allergy 2015, 8:93-103

Published Date: 23 September 2015

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide

Price D, Kaplan A, Jones R, Freeman D, Burden A, Gould S, von Ziegenweidt J, Ali M, King C, Thomas M

Journal of Asthma and Allergy 2015, 8:1-13

Published Date: 14 January 2015

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD

Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WMC, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1163-1186

Published Date: 17 October 2014

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:889-905

Published Date: 27 August 2014

Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease

Brockwell C, Ampikaipakan S, Sexton DW, Price D, Freeman D, Thomas M, Ali M, Wilson AM

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:715-721

Published Date: 9 July 2014

Switching patients from other inhaled corticosteroid devices to the Easyhaler®: historical, matched-cohort study of real-life asthma patients

Price D, Thomas V, von Ziegenweidt J, Gould S, Hutton C, King C

Journal of Asthma and Allergy 2014, 7:31-51

Published Date: 10 April 2014

Impact of night-time symptoms in COPD: a real-world study in five European countries

Price D, Small M, Milligan G, Higgins V, Garcia Gil E, Estruch J

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:595-603

Published Date: 27 November 2013

The challenge of recruiting in primary care for a trial of telemonitoring in asthma: an observational study

Malhotra S, Musgrave SD, Pinnock H, Price D, Ryan DP

Pragmatic and Observational Research 2012, 3:51-55

Published Date: 24 August 2012

Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD

Price D, Haughney J, Sims E, Ali M, von Ziegenweidt J, Hillyer EV, Lee AJ, Chisholm A, Barnes N

Journal of Asthma and Allergy 2011, 4:37-47

Published Date: 28 April 2011